Metabolic engineering of Corynebacterium glutamicum for shikimate overproduction by growth-arrested cell reaction

Corynebacterium glutamicum with the ability to simultaneously utilize glucose/pentose mixed sugars was metabolically engineered to overproduce shikimate, a valuable hydroaromatic compound used as a starting material for the synthesis of the anti-influenza drug oseltamivir. To achieve this, the shiki...

Full description

Saved in:
Bibliographic Details
Published in:Metabolic engineering 2016-11, Vol.38, p.204-216
Main Authors: Kogure, Takahisa, Kubota, Takeshi, Suda, Masako, Hiraga, Kazumi, Inui, Masayuki
Format: Article
Language:English
Subjects:
Cell Proliferation - physiology
Corynebacterium glutamicum
Corynebacterium glutamicum - cytology
Corynebacterium glutamicum - physiology
Escherichia coli - genetics
Genetic Enhancement - methods
Glucose - metabolism
Metabolic engineering
Metabolic Engineering - methods
Metabolic Networks and Pathways - physiology
Oseltamivir
Pentoses - metabolism
Phosphoenolpyruvate
Phosphotransferases (Alcohol Group Acceptor) - genetics
Phosphotransferases (Alcohol Group Acceptor) - metabolism
Recombinant Proteins - genetics
Recombinant Proteins - metabolism
Shikimate pathway
Shikimic acid
Shikimic Acid - metabolism
Sugars - metabolism
Up-Regulation - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Corynebacterium glutamicum with the ability to simultaneously utilize glucose/pentose mixed sugars was metabolically engineered to overproduce shikimate, a valuable hydroaromatic compound used as a starting material for the synthesis of the anti-influenza drug oseltamivir. To achieve this, the shikimate kinase and other potential metabolic activities for the consumption of shikimate and its precursor dehydroshikimate were inactivated. Carbon flux toward shikimate synthesis was enhanced by overexpression of genes for the shikimate pathway and the non-oxidative pentose phosphate pathway. Subsequently, to improve the availability of the key aromatics precursor phosphoenolpyruvate (PEP) toward shikimate synthesis, the PEP: sugar phosphotransferase system (PTS) was inactivated and an endogenous myo-inositol transporter IolT1 and glucokinases were overexpressed. Unexpectedly, the resultant non-PTS strain accumulated 1,3-dihydroxyacetone (DHA) and glycerol as major byproducts. This observation and metabolome analysis identified glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-catalyzed reaction as a limiting step in glycolysis. Consistently, overexpression of GAPDH significantly stimulated both glucose consumption and shikimate production. Blockage of the DHA synthesis further improved shikimate yield. We applied an aerobic, growth-arrested and high-density cell reaction to the shikimate production by the resulting strain and notably achieved the highest shikimate titer (141g/l) and a yield (51% (mol/mol)) from glucose reported to date after 48h in minimal medium lacking nutrients required for cell growth. Moreover, comparable shikimate productivity could be attained through simultaneous utilization of glucose, xylose, and arabinose, enabling efficient shikimate production from lignocellulosic feedstocks. These findings demonstrate that C. glutamicum has significant potential for the production of shikimate and derived aromatic compounds. •Engineered strain achieved the highest shikimate productivity reported to date.•141g/L of shikimate was produced from glucose at a yield of 51% after 48h.•A novel aerobic growth-arrested cell reaction developed for shikimate production.•Engineering of the sugar uptake route and glycolytic pathway enhanced productivity.•Shikimate overproduction through simultaneous utilization of mixed sugars.
ISSN:1096-7176
1096-7184
DOI:10.1016/j.ymben.2016.08.005